CH587021A5
(es)
|
1974-06-07 |
1977-04-29 |
Nestle Sa |
|
EP0173552B1
(en)
|
1984-08-24 |
1991-10-09 |
The Upjohn Company |
Recombinant dna compounds and the expression of polypeptides such as tpa
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
US5651991A
(en)
|
1987-10-28 |
1997-07-29 |
Nippon Shinyaku Co. Ltd. |
Drug carriers
|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
US5252334A
(en)
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
JP3218637B2
(ja)
|
1990-07-26 |
2001-10-15 |
大正製薬株式会社 |
安定なリポソーム水懸濁液
|
JP2958076B2
(ja)
|
1990-08-27 |
1999-10-06 |
株式会社ビタミン研究所 |
遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
JPH07285863A
(ja)
|
1994-02-25 |
1995-10-31 |
Takeda Chem Ind Ltd |
注射剤組成物およびその製造方法
|
ES2078190B1
(es)
|
1994-05-20 |
1996-08-01 |
Cusi Lab |
Procedimiento para el recubrimiento de goticulas o particulas de tamaño nanometrico.
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
US5697899A
(en)
|
1995-02-07 |
1997-12-16 |
Gensia |
Feedback controlled drug delivery system
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
US5738868A
(en)
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
US5656016A
(en)
|
1996-03-18 |
1997-08-12 |
Abbott Laboratories |
Sonophoretic drug delivery system
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
US5783208A
(en)
|
1996-07-19 |
1998-07-21 |
Theratech, Inc. |
Transdermal drug delivery matrix for coadministering estradiol and another steroid
|
US5779708A
(en)
|
1996-08-15 |
1998-07-14 |
Cyberdent, Inc. |
Intraosseous drug delivery device and method
|
WO1998010088A1
(en)
|
1996-09-06 |
1998-03-12 |
Trustees Of The University Of Pennsylvania |
An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
|
US6007856A
(en)
|
1997-08-08 |
1999-12-28 |
The Procter & Gamble Company |
Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
|
EP0953632B1
(de)
|
1998-03-30 |
2007-09-05 |
Mibelle AG Cosmetics |
Verwendung von Nanoemulsionen zur Bestimmung der Biokompatibilität von lipophilen Stoffen im Zellkultur-Test und dafür geeignete Nanoemulsionen
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
US8026096B1
(en)
|
1998-10-08 |
2011-09-27 |
Protein Sciences Corporation |
In vivo active erythropoietin produced in insect cells
|
EP1144009B1
(en)
|
1998-12-03 |
2002-10-23 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
FR2787728B1
(fr)
|
1998-12-23 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
US6258595B1
(en)
|
1999-03-18 |
2001-07-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
WO2001025253A2
(en)
|
1999-10-01 |
2001-04-12 |
The University Of North Carolina At Chapel Hill |
Temperature-sensitive regulation of viral vector production
|
AU3274401A
(en)
|
2000-01-05 |
2001-07-16 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for efficient aav vector production
|
US7060497B2
(en)
|
2000-03-03 |
2006-06-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adeno-associated viral vector-based methods and compositions for introducing an expression cassette into a cell
|
DE60138804D1
(de)
|
2000-03-23 |
2009-07-09 |
Basf Catalysts Llc |
Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft
|
WO2001070972A2
(en)
|
2000-03-24 |
2001-09-27 |
Yasunaga, Shin'ichiro |
Multiple human and mouse otoferlin isoforms
|
RS49646B
(sr)
|
2000-07-04 |
2007-09-21 |
Slobodan Arsenijević |
Instrument za ubrizgavanje fluida i dilataciona sonda za uvođenje u telesne šupljine
|
FR2811561B1
(fr)
|
2000-07-13 |
2003-03-21 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
|
US6593123B1
(en)
|
2000-08-07 |
2003-07-15 |
Avigen, Inc. |
Large-scale recombinant adeno-associated virus (rAAV) production and purification
|
US6329181B1
(en)
|
2000-08-07 |
2001-12-11 |
Neurologix, Inc. |
Helper functions for recombinant vector production
|
US20040048836A1
(en)
|
2001-03-23 |
2004-03-11 |
Wilmott James M |
Method for preparing high pressure/ high shear dispersions containing physiologically active ingredients
|
AU2002258644B2
(en)
|
2001-03-30 |
2006-12-14 |
Color Access, Inc. |
Novel nanoemulsions
|
KR100463167B1
(ko)
|
2001-04-13 |
2004-12-23 |
주식회사 태평양 |
고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
|
JP2006512401A
(ja)
|
2001-06-05 |
2006-04-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
ナノエマルジョンワクチン
|
ES2564553T3
(es)
|
2001-08-08 |
2016-03-23 |
The Trustees Of The University Of Pennsylvania |
Procedimiento para purificar vectores víricos que tienen proteínas que se unen a ácido siálico
|
US20040115159A1
(en)
|
2002-03-29 |
2004-06-17 |
Tadlock Charles C |
Novel nanoemulsions
|
US7071172B2
(en)
|
2002-04-30 |
2006-07-04 |
The University Of North Carolina At Chapel Hill |
Secretion signal vectors
|
US7419817B2
(en)
|
2002-05-17 |
2008-09-02 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. |
Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
|
US6864336B2
(en)
|
2002-09-12 |
2005-03-08 |
3M Innovative Properties Company |
Fluoroelastomers having low temperature characteristics and solvent resistance
|
US7329688B2
(en)
|
2002-12-17 |
2008-02-12 |
Soft Gel Technologies, Inc. |
Natural vitamin E compositions with superior antioxidant potency
|
JP4559429B2
(ja)
|
2003-05-21 |
2010-10-06 |
ジェンザイム・コーポレーション |
空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
|
EP1633322A2
(en)
|
2003-06-04 |
2006-03-15 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
|
KR20060052849A
(ko)
|
2003-08-06 |
2006-05-19 |
에자이 가부시키가이샤 |
약물 초미립자의 제조 방법 및 제조 장치
|
US7387614B2
(en)
|
2003-08-26 |
2008-06-17 |
University Of Maryland, Baltimore |
Drug delivery to the inner ear and methods of using same
|
EP1510206A1
(en)
|
2003-08-29 |
2005-03-02 |
Novagali Pharma SA |
Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
|
KR20060110872A
(ko)
|
2003-10-29 |
2006-10-25 |
소너스파머슈티칼즈인코포레이티드 |
토코페롤 변성 치료제 약물 화합물
|
WO2005073384A2
(en)
|
2004-01-28 |
2005-08-11 |
Research Development Foundation |
Human soluble neuropilin-1 primary polyadenylation signal and uses thereof
|
WO2005084452A1
(en)
|
2004-02-23 |
2005-09-15 |
The Texas A & M University System |
Antioxidant compositions and methods of use thereof
|
US7419497B2
(en)
|
2004-04-21 |
2008-09-02 |
Acclarent, Inc. |
Methods for treating ethmoid disease
|
EP1751275B1
(en)
|
2004-06-01 |
2017-08-16 |
Avigen, Inc. |
Compositions and methods to prevent aav vector aggregation
|
CA2571159A1
(en)
|
2004-06-18 |
2006-03-30 |
The University Of Montana |
Aav mediated gene delivery to cochlear cells
|
US20060040354A1
(en)
|
2004-07-20 |
2006-02-23 |
O'keefe Theresa L |
Novel polyadenylation signal for use in expression vectors
|
US20070055199A1
(en)
|
2005-08-10 |
2007-03-08 |
Gilbert Scott J |
Drug delivery device for buccal and aural applications and other areas of the body difficult to access
|
PT3272872T
(pt)
|
2005-10-20 |
2020-06-26 |
Uniqure Ip Bv |
Vetores aav melhorados produzidos em células de insetos
|
EP2018421B1
(en)
|
2006-04-28 |
2012-12-19 |
The Trustees of the University of Pennsylvania |
Scalable production method for aav
|
US7851196B2
(en)
|
2006-05-01 |
2010-12-14 |
The Regents Of The University Of California |
Methods for purifying adeno-associated virus particles
|
CA2921594A1
(en)
|
2006-06-21 |
2007-12-27 |
Uniqure Ip B.V. |
Aav vectors with improved rep coding sequences for production in insect cells
|
US20080065002A1
(en)
|
2006-09-07 |
2008-03-13 |
Neurosystec Corporation |
Catheter for Localized Drug Delivery and/or Electrical Stimulation
|
PL2173888T3
(pl)
|
2007-07-26 |
2017-02-28 |
Uniqure Ip B.V. |
Wektory bakulowirusowe zawierające powtórzone sekwencje kodujące o zróżnicowanej preferencji kodonów
|
US20090042825A1
(en)
|
2007-08-06 |
2009-02-12 |
Majed Matar |
Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
|
US8236557B2
(en)
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
EP3372687B1
(en)
|
2008-11-28 |
2022-01-12 |
Anton Bauer |
Artificial chromosome vector
|
SI3444335T1
(sl)
|
2009-06-16 |
2021-08-31 |
Genzyme Corporation |
Izboljšani postopki čiščenja vektorjev rekombinantnega AAV
|
JP5697123B2
(ja)
|
2009-07-27 |
2015-04-08 |
国立大学法人 千葉大学 |
酸性化ポリエチレンイミンを用いる細胞への核酸導入方法
|
WO2011075838A1
(en)
|
2009-12-21 |
2011-06-30 |
Audigen Inc. |
Method of treating or preventing hearing loss
|
BR112012018899A2
(pt)
|
2010-01-28 |
2015-09-15 |
Philadelphia Children Hospital |
"método para purificar partículas de vetor de vírus adeno-associado."
|
WO2011112089A2
(en)
|
2010-03-11 |
2011-09-15 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Mutated rep encoding sequences for use in aav production
|
WO2012022920A1
(fr)
|
2010-08-19 |
2012-02-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Dispositif implantable dans l'os temporal pour administrer un produit et prothèse auditive pourvue d'un tel dispositif.
|
EP2500434A1
(en)
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
US8852165B2
(en)
|
2011-06-16 |
2014-10-07 |
II Edward G. Mackay |
Endoluminal drug delivery devices and methods
|
ES2609860T3
(es)
|
2011-10-28 |
2017-04-24 |
The University Of North Carolina At Chapel Hill |
Línea celular para la producción de virus adenoasociado
|
WO2013075008A1
(en)
|
2011-11-16 |
2013-05-23 |
University Of Florida Research Foundation Inc. |
Aav dual vector systems for gene therapy
|
AU2013221212B2
(en)
|
2012-02-17 |
2018-08-09 |
The Children's Hospital Of Philadelphia |
AAV vector compositions and methods for gene transfer to cells, organs and tissues
|
US11332719B2
(en)
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
US10494645B2
(en)
|
2013-04-18 |
2019-12-03 |
Fondazione Telethon |
Effective delivery of large genes by dual AAV vectors
|
EP3039129B1
(en)
|
2013-08-30 |
2018-06-27 |
Amgen Inc. |
High titer recombinant aav vector production in adherent and suspension cells
|
EP3744730A1
(en)
|
2013-10-11 |
2020-12-02 |
Massachusetts Eye & Ear Infirmary |
Methods of predicting ancestral virus sequences and uses thereof
|
IL247729B2
(en)
|
2014-03-10 |
2023-09-01 |
Uniqure Ip Bv |
Improved aav vectors produced in insect cells
|
US10526583B2
(en)
|
2014-07-02 |
2020-01-07 |
University Of Florida Research Foundation, Incorporated |
Compositions and methods for purifying recombinant adeno-associated virus
|
WO2016114992A2
(en)
|
2015-01-13 |
2016-07-21 |
Alfa Wassermann, Inc. |
Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav) and gradients and flow-through buffers therefore
|
EP3054006A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
|
EP3258955A1
(en)
|
2015-02-20 |
2017-12-27 |
Institut Pasteur |
Prevention and/or treatment of hearing loss or impairment
|
PT3265571T
(pt)
|
2015-03-03 |
2022-06-29 |
Fond Telethon |
Sistema de vetor múltiplo e uso do mesmo
|
JP6812368B2
(ja)
|
2015-03-06 |
2021-01-13 |
マサチューセッツ アイ アンド イヤー インファーマリー |
Prpf31遺伝子における変異により引き起こされる遺伝性網膜変性に対する遺伝子増強療法
|
CA2994160C
(en)
|
2015-07-30 |
2021-08-10 |
Massachusetts Eye And Ear Infirmary |
Ancestral virus sequences and uses thereof
|
IL259595B2
(en)
|
2015-12-01 |
2024-01-01 |
Spark Therapeutics Inc |
Gradual methods for the production of a recombinant adenovirus (AAV) vector in a serum-free suspension cell culture system suitable for clinical use
|
SG10201913266UA
(en)
|
2015-12-11 |
2020-02-27 |
Massachusetts Eye & Ear Infirmary |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
US11072803B2
(en)
|
2015-12-22 |
2021-07-27 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Hybrid dual recombinant AAV vector systems for gene therapy
|
WO2017132530A1
(en)
|
2016-01-29 |
2017-08-03 |
Massachusetts Eye And Ear Infirmary |
Expansion and differentiation of inner ear supporting cells and methods of use thereof
|
US20190038778A1
(en)
|
2016-02-05 |
2019-02-07 |
The General Hospital Corporation |
Hybrid System for Efficient Gene Delivery to Cells of the Inner Ear
|
AU2017281086A1
(en)
|
2016-06-22 |
2019-02-07 |
Mass Eye And Ear Infirmary |
A system for inner ear drug delivery via trans-round window membrane injection
|
GB201612248D0
(en)
|
2016-07-14 |
2016-08-31 |
Puridify Ltd |
New process
|
AU2017299779B2
(en)
|
2016-07-21 |
2021-12-02 |
Spark Therapeutics, Inc. |
Scalable high recovery methods for producing high yield recombinant adeno-associated viral (rAAV) vector and recombinant adeno-associated viral (rAAV) vectors produced thereby
|
KR20230161535A
(ko)
|
2016-07-26 |
2023-11-27 |
바이오마린 파머수티컬 인크. |
신규 아데노-관련 바이러스 캡시드 단백질
|
CA3034527A1
(en)
|
2016-08-23 |
2018-03-01 |
Emmanuel John Simons |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
CN109844424B
(zh)
*
|
2016-10-24 |
2022-02-11 |
康明斯有限公司 |
车辆废热回收冷却优化
|
PT3535388T
(pt)
|
2016-11-04 |
2023-06-27 |
Takeda Pharmaceuticals Co |
Métodos de purificação de vírus adeno-associados
|
US10626376B2
(en)
|
2016-11-14 |
2020-04-21 |
St. Jude Children's Research Hospital |
Method for isolating and purifying adeno-associated virus particles using salt
|
CA3052704A1
(en)
|
2017-02-06 |
2018-08-09 |
Children's Medical Center Corporation |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
CA3061652A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
SG11201909868YA
(en)
|
2017-05-05 |
2019-11-28 |
Voyager Therapeutics Inc |
Compositions and methods of treating huntington's disease
|
US20200270635A1
(en)
|
2017-05-05 |
2020-08-27 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
WO2018204734A1
(en)
|
2017-05-05 |
2018-11-08 |
University Of Florida Research Foundation, Incorporated |
Compositions and methods for expressing otoferlin
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
EP3662060A2
(en)
|
2017-08-03 |
2020-06-10 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
US11439749B2
(en)
|
2017-10-25 |
2022-09-13 |
The Charles Stark Draper Laboratory, Inc. |
Apparatus and method for trans-round window membrane drug delivery
|
CA3088723A1
(en)
|
2018-01-16 |
2019-07-25 |
Cls Therapeutics Limited |
Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (dnase) activity
|
AU2019218232A1
(en)
|
2018-02-09 |
2020-09-24 |
Decibel Therapeutics, Inc. |
Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
|
DE102018103924A1
(de)
|
2018-02-21 |
2019-08-22 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Gentherapeutische Behandlung von Schwerhörigkeit
|
BR112020016919A2
(pt)
|
2018-02-22 |
2020-12-15 |
Akouos, Inc. |
Composições e métodos para tratamento da deficiência auditiva não associada à idade em um sujeito humano
|
CA3093490A1
(en)
|
2018-03-05 |
2019-09-12 |
Children's Medical Center Corporation |
Compositions and methods for delivering nucleic acids to cochlear and vestibular cells
|
WO2019210181A1
(en)
|
2018-04-27 |
2019-10-31 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
US11660353B2
(en)
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
US20210230632A1
(en)
|
2018-05-15 |
2021-07-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
JP2021523914A
(ja)
|
2018-05-15 |
2021-09-09 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. |
パーキンソン病を治療するための組成物および方法
|
BR112021000327A2
(pt)
|
2018-07-11 |
2021-04-06 |
Baxalta Incorporated |
Composições de aav
|
AU2019310459A1
(en)
|
2018-07-24 |
2021-02-18 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
EP3856227A4
(en)
|
2018-09-27 |
2022-07-06 |
Akouos, Inc. |
METHOD OF TREATMENT OF AN AUDITORY NEUROPATHY SPECTRUM DISORDER
|
WO2020077295A1
(en)
|
2018-10-11 |
2020-04-16 |
Decibel Therapeutics, Inc. |
Aav1 vectors and uses thereof for treatment of otic indications
|
US20210395778A1
(en)
|
2018-11-01 |
2021-12-23 |
University Of Florida Research Foundation, Incorporated |
A codon optimized otoferlin aav dual vector gene therapy
|
EP3880826A4
(en)
|
2018-11-07 |
2022-08-24 |
Akouos, Inc. |
USE OF ADENO-ASSOCIATED VIRAL VECTORS TO CORRECT GENE DEFECTS/EXPRESS PROTEINS IN CILIATE AND SUPPORTING CELLS IN THE INNER EAR
|
PL3911354T3
(pl)
|
2019-01-18 |
2024-03-11 |
Institut Pasteur |
Terapia genowa zależna od aav przywracająca gen otoferliny
|
CN110437317B
(zh)
|
2019-01-30 |
2023-05-02 |
上海科技大学 |
具有变异衣壳蛋白的腺相关病毒及其用途
|
US20210388045A1
(en)
|
2019-02-08 |
2021-12-16 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
WO2020163743A1
(en)
|
2019-02-08 |
2020-08-13 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
CN114072179A
(zh)
|
2019-02-08 |
2022-02-18 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
US20220233715A1
(en)
|
2019-05-08 |
2022-07-28 |
Center For Excellence In Brain Science And Intelligence Technology, Chinese Academy Of Sciences |
Aav mutant that efficiently infects supporting cells
|
EP4037771A4
(en)
|
2019-09-30 |
2023-10-25 |
Applied Genetic Technologies Corporation |
ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATING GENETIC HEARING LOSS
|
WO2021077115A1
(en)
|
2019-10-18 |
2021-04-22 |
Research Institute At Nationwide Children's Hospital |
Gene therapy targeting cochlear cells
|
BR112022008214A2
(pt)
|
2019-10-30 |
2022-07-12 |
Decibel Therapeutics Inc |
Composições e métodos para tratar perda auditiva neurossensorial usando sistemas de vetor duplo de otoferlina
|
KR20220113940A
(ko)
|
2019-11-11 |
2022-08-17 |
솔크 인스티튜트 포 바이올로지칼 스터디즈 |
Rna 분자의 고-효율 재조합을 위한 조성물 및 방법
|
CN113840915A
(zh)
|
2020-01-24 |
2021-12-24 |
***合众国, 由健康及人类服务部部长代表 |
腺相关病毒及其用于内耳疗法的用途
|
CN115335526A
(zh)
|
2020-02-07 |
2022-11-11 |
罗切斯特大学 |
核酶介导的rna组装和表达
|
JP2023512824A
(ja)
|
2020-02-07 |
2023-03-29 |
ザ チルドレンズ メディカル センター コーポレーション |
大型遺伝子ベクターならびにその送達および使用の方法
|
IL295747A
(en)
*
|
2020-02-21 |
2022-10-01 |
Akouos Inc |
Preparations and methods for the treatment of hearing impairment that is not related to age in humans
|
EP4118097A4
(en)
|
2020-03-12 |
2024-05-15 |
California Institute of Technology |
ADENO-ASSOCIATED VIRAL CAPSIDS WITH EXPANDED SIZES
|
CN111349148A
(zh)
|
2020-03-13 |
2020-06-30 |
辉大(上海)生物科技有限公司 |
一种腺相关病毒载体及其用途
|
EP3885440A1
(en)
|
2020-03-26 |
2021-09-29 |
Splicebio, S.L. |
Split inteins and their uses
|
US20240016955A1
(en)
|
2020-09-14 |
2024-01-18 |
President And Fellows Of Harvard College |
Dual-aav vector delivery of pcdh15 and uses thereof
|
KR20230117731A
(ko)
|
2020-11-06 |
2023-08-09 |
일라이 릴리 앤드 캄파니 |
청력 상실의 치료를 위한 변이체 아데노-연관된 바이러스(aav) 캡시드 폴리펩티드 및 이의 유전자 치료제
|
EP4008788A1
(en)
|
2020-12-03 |
2022-06-08 |
Medizinische Hochschule Hannover |
Lentiviral vector technology for inner ear gene therapy
|
MX2023009714A
(es)
|
2021-02-19 |
2023-10-03 |
Decibel Therapeutics Inc |
Metodos para el tratamiento de la perdida auditiva neurosensorial mediante el uso de sistemas de vectores duales de otoferlina.
|
CN113337507B
(zh)
|
2021-08-05 |
2021-11-12 |
首都医科大学附属北京友谊医院 |
Otof 1273 (C>T)基因定点突变的耳聋小鼠模型的构建方法及其应用
|